Literature DB >> 19166840

FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.

Anna Maria Ochocka1, Petros Kampanis, Samantha Nicol, Nerea Allende-Vega, Miranda Cox, Lynnette Marcar, Diane Milne, Frances Fuller-Pace, David Meek.   

Abstract

The p53 tumour suppressor protein is tightly controlled by the E3 ubiquitin ligase, mouse double minute 2 (MDM2), but maintains MDM2 expression as part of a negative feedback loop. We have identified the immunophilin, 25kDa FK506-binding protein (FKBP25), previously shown to be regulated by p53-mediated repression, as an MDM2-interacting partner. We show that FKBP25 stimulates auto-ubiquitylation and proteasomal degradation of MDM2, leading to the induction of p53. Depletion of FKBP25 by siRNA leads to increased levels of MDM2 and a corresponding reduction in p53 and p21 levels. These data are consistent with the idea that FKBP25 contributes to regulation of the p53-MDM2 negative feedback loop.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166840     DOI: 10.1016/j.febslet.2009.01.009

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

Review 1.  The emerging role of peptidyl-prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease.

Authors:  Laura J Blair; Jeremy D Baker; Jonathan J Sabbagh; Chad A Dickey
Journal:  J Neurochem       Date:  2015-02-24       Impact factor: 5.372

2.  Adamantyl derivative as a potent inhibitor of Plasmodium FK506 binding protein 35.

Authors:  Amaravadhi Harikishore; Min Li Leow; Makhtar Niang; Sreekanth Rajan; Kalyan Kumar Pasunooti; Peter Rainer Preiser; Xuewei Liu; Ho Sup Yoon
Journal:  ACS Med Chem Lett       Date:  2013-09-16       Impact factor: 4.345

Review 3.  Prolyl isomerases in gene transcription.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-10-31

Review 4.  Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.

Authors:  Melanie Gerard; Angélique Deleersnijder; Jonas Demeulemeester; Zeger Debyser; Veerle Baekelandt
Journal:  Mol Neurobiol       Date:  2011-05-07       Impact factor: 5.590

Review 5.  Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands.

Authors:  Andrzej Galat
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

6.  Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Authors:  Paola Dongiovanni; Anna Ludovica Fracanzani; Gaetano Cairo; Chiara Paola Megazzini; Stefano Gatti; Raffaela Rametta; Silvia Fargion; Luca Valenti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

7.  Crystal structure of the FK506 binding domain of human FKBP25 in complex with FK506.

Authors:  Ajit Prakash; Sreekanth Rajan; Ho Sup Yoon
Journal:  Protein Sci       Date:  2016-02-01       Impact factor: 6.725

Review 8.  Protein quality control system in neurodegeneration: a healing company hard to beat but failure is fatal.

Authors:  Deepak Chhangani; Amit Mishra
Journal:  Mol Neurobiol       Date:  2013-02-03       Impact factor: 5.590

9.  HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas.

Authors:  Angela M Sosin; Angelika M Burger; Aisha Siddiqi; Judith Abrams; Ramzi M Mohammad; Ayad M Al-Katib
Journal:  J Hematol Oncol       Date:  2012-09-18       Impact factor: 17.388

10.  Tacrolimus (FK506) prevents early stages of ethanol induced hepatic fibrosis by targeting LARP6 dependent mechanism of collagen synthesis.

Authors:  Zarko Manojlovic; John Blackmon; Branko Stefanovic
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.